Loading...
A036480 logo

Daesung Microbiological Labs. Co., Ltd.KOSDAQ:A036480 Stock Report

Market Cap ₩25.5b
Share Price
₩6.72k
₩491.79
1.3k% overvalued intrinsic discount
1Y-19.5%
7D1.1%
1D
Portfolio Value
View

Daesung Microbiological Labs. Co., Ltd.

KOSDAQ:A036480 Stock Report

Market Cap: ₩25.5b

Daesung Microbiological Labs (A036480) Stock Overview

Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. More details

A036480 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends2/6

A036480 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Daesung Microbiological Labs. Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Daesung Microbiological Labs
Historical stock prices
Current Share Price₩6,720.00
52 Week High₩10,960.00
52 Week Low₩6,100.00
Beta0.18
1 Month Change-12.61%
3 Month Change-5.35%
1 Year Change-19.52%
3 Year Change-44.09%
5 Year Change-67.14%
Change since IPO-63.48%

Recent News & Updates

Recent updates

Analysis Article Aug 06

Daesung Microbiological Labs (KOSDAQ:036480) Is Carrying A Fair Bit Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article May 08

Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Mar 15

Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Daesung Microbiological Labs (KOSDAQ:036480) has had a rough month with its share price down 9.5%. We, however decided...
Analysis Article Feb 17

We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Analysis Article Jan 21

Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article Dec 31

Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Analysis Article Dec 10

Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Daesung Microbiological Labs' (KOSDAQ:036480) stock is up by 4.3% over the past month. However, the company's...
Analysis Article Nov 19

Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. However...

Shareholder Returns

A036480KR BiotechsKR Market
7D1.1%5.3%10.4%
1Y-19.5%28.1%188.7%

Return vs Industry: A036480 underperformed the KR Biotechs industry which returned 28.1% over the past year.

Return vs Market: A036480 underperformed the KR Market which returned 188.7% over the past year.

Price Volatility

Is A036480's price volatile compared to industry and market?
A036480 volatility
A036480 Average Weekly Movement12.2%
Biotechs Industry Average Movement11.5%
Market Average Movement9.5%
10% most volatile stocks in KR Market16.6%
10% least volatile stocks in KR Market4.9%

Stable Share Price: A036480 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A036480's weekly volatility has increased from 6% to 12% over the past year, but is still lower than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1966n/aHang-Won Chowww.dsmbio.co.kr

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products.

Daesung Microbiological Labs. Co., Ltd. Fundamentals Summary

How do Daesung Microbiological Labs's earnings and revenue compare to its market cap?
A036480 fundamental statistics
Market cap₩25.54b
Earnings (TTM)₩598.19m
Revenue (TTM)₩25.99b
42.7x
P/E Ratio
1.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A036480 income statement (TTM)
Revenue₩25.99b
Cost of Revenue₩19.67b
Gross Profit₩6.32b
Other Expenses₩5.72b
Earnings₩598.19m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)157.42
Gross Margin24.32%
Net Profit Margin2.30%
Debt/Equity Ratio55.4%

How did A036480 perform over the long term?

See historical performance and comparison

Dividends

1.1%
Current Dividend Yield
n/a
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/27 17:48
End of Day Share Price 2026/05/27 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daesung Microbiological Labs. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.